PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Bio-Technology, Vignan\'s Foundation for Science, Technology & Research, Vadlamudi, 522213, Andhra Pradesh, India.\', \'Division of Life Science, Department of Bio & Medical Big Data (BK4 Program), Research Institute of Natural Science (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 52828, Republic of Korea.\', \'Division of Applied Life Sciences, Gyeongsang National University (GNU), 501 Jinju-daero, Jinju, 52828, Republic of Korea.\', \'Division of Life Science, Department of Bio & Medical Big Data (BK4 Program), Research Institute of Natural Science (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 52828, Republic of Korea. Electronic address: kwlee@gnu.ac.kr.\', \'Department of Bio-Technology, Vignan\'s Foundation for Science, Technology & Research, Vadlamudi, 522213, Andhra Pradesh, India. Electronic address: venki_biotech327@yahoo.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0022-3549(21)00151-910.1016/j.xphs.2021.03.004
?:hasPublicationType
?:journal
  • Journal of pharmaceutical sciences
is ?:pmid of
?:pmid
?:pmid
  • 33684397
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.984
?:rankingScore_hIndex
  • 149
is ?:relation_isRelatedTo_publication of
?:title
  • Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33684397>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33684397>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all